TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reduction in hypnotic medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: thermal pain tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MPA 12-h areas under the curve (MPA-AUC0-12 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean residence times (MRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean absolute pulmonary bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cesarean sections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cumulative risk of secondary AML
Endpoint domain: Mortality/survival
Primary endpoint: Postprandial glucose parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in HOMAIR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak saccade velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Shifting attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: D‐dimer level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 2‐LTR circles level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of DH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total acid produced after brushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: re-infarction incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage of admissions with unstable angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PASI100 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean number of polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean polyp size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of postoperative atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronal tibiofemoral angle malalignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin and nasal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knot tying abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: comprehension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean static pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cosmetic survey score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Systemic exposure based on AUC0‐∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of drug‐drug interactions
Endpoint domain: Adverse events/effects
Primary endpoint: Total lipids in the proximal jejunum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Free fatty acid concentrations over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cholesterol: high density lipoprotein ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum SLPI concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal multiple organ dysfunction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial very low density lipoprotein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulinemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of survival without bronchopulmonary dysplasia (BPD)
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in erythrocyte and hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in mortality at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Glycemic Load (GL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Core 1 error rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cough frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Lactate Decrease (BLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Torque Increase (PT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients classified as 'Risk' for moderate renal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: number of hypotension episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Agreement between self- and telephone-administered SCREEN II scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bacterial microleakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total social functioning score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Acceptability ratings of sessions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased use of BCTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Respiratory responding (CO2 decrease, minute ventilation increase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: therapeutic effects on angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive functioning in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Family activities limitation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of venous thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incremental costs of the holography-augmented method
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participants' preferences for teaching methods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in performing simple interrupted sutures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cope with cancer, treatment, and physical symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improve mental well‐being, attention, and appreciation for the self and body
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improve total functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean area of bruising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protection against treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Attitudes toward sexual risk-taking behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in flexor tone in the wrist and fingers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement on the Disability Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in diagnostic work-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in therapeutic plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of TDF-FTC in preventing HIV infection
Endpoint domain: Mortality/survival
Primary endpoint: Decline in bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriateness of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Appropriateness of risk perception
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Severity of OCB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-injurious behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall hazardous consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of visual function measured by LCVA
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Worsening of HCVA
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Behavioural measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adherence to CBT
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Rate of pacing-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: average self-selected walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: E1, E2 and E1S levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Stunting at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linear growth 0-24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Skeletal changes (SNA, SNB, ANB, mandibular plane angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-intervention improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changing levels of glucose, insulin, and triglycerides at 60 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GLP-1 levels at 120 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reactive hyperemia duration at 120 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NFT (Number of Failed Attempts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to ERC guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for LTS-D over BMV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clearance of beta(2)m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre-dialysis concentration of beta(2)m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: agitated behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of OC symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain severity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-procedure mean peak of Scr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Post-procedure increase in Scr levels from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: cosmetic deformity
Endpoint domain: Adverse events/effects
Primary endpoint: general complications
Endpoint domain: Adverse events/effects
Primary endpoint: time required for thrombolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minor complications (mainly bleeding events)
Endpoint domain: Adverse events/effects
Primary endpoint: Relative humidity (RH) of inspired gases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute humidity (AH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracheal temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: E-RS cough/sputum domain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of morning cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Night-time cough frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Death rates at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Cardiac death rates at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Time to discharge from hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total fentanyl requirement in recovery room
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction at 24 hours postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of sexual function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: verbal learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Balloon inflation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of BED symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence from opiates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of disfigurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight gain from entry to 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum urea at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total plasma essential amino acids at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inclination to treat non-smoker vs smoker
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Suicide attempts during treatment phase
Endpoint domain: Adverse events/effects
Primary endpoint: Suicide attempts during follow-up period
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of stain considered unacceptable
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Doppler flow through the femoral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Eating Disorder Examination Questionnaire global scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Circulating oxidative protein modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay (LOS) within the first 90 days of transplantation
Endpoint domain: Resource use
Primary endpoint: Peak urinary flow rate increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Preference for brief verbal consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: measure of hopelessness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall accuracy of dermatologists in the diagnosis of nail matrix melanoma in situ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: affected arm use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARA score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular disease mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: hematocrit values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of ketoacidosis
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality of ARDS patients after PMX-F treatment
Endpoint domain: Mortality/survival
Primary endpoint: Blood MMP-9 levels in ARDS patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood TIMP-1 levels in ARDS patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Error scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PCL damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: drainage duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coagulation profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of low respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Supplemental oxygen requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of breathing prompts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean day 4 neutrophil counts as % baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: NoL (Noxious stimulation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraprostatic DHT and testosterone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: VAS scores in the postanesthetic recovery unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean iclaprim concentrations in ELF and AM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity for malignant microcalcifications detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the ROC curve of Score I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C peptide secretion in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insulin dose/kg body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in quality of life score (EQ5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall self-assessment of health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean cost per abstinent patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in global acne severity ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum levels of leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean serum levels of testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Patient preference for diet
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Median clearance of AKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of lung injury
Endpoint domain: Adverse events/effects
Primary endpoint: Readmission within 14 days after ACS
Endpoint domain: Mortality/survival
Primary endpoint: Ang II-mediated vasoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mRNA expression of AT1-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mRNA expression of AT2-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CRC development rate
Endpoint domain: Mortality/survival
Primary endpoint: Mean deviation from prescribed contraction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric hip and knee strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of CRBSIs
Endpoint domain: Adverse events/effects
Primary endpoint: Spherical equivalent within +/‐0.5 D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of ablation decentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ‐5D utility score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: composite cardiovascular endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean score on abdominal OSCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognition and Processing Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive Style
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Social Cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Social Adjustment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: dyspnea
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: emotional function
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mastery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention